LXRX - Lexicon appoints Mike Exton as CEO Jeff Wade as COO
2024-07-08 13:11:29 ET
More on Lexicon Pharmaceuticals
- Lexicon Pharmaceuticals: Blue Sky Aplenty, Revenue Not So Much
- Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2024 Earnings Call Transcript
- Lexicon resubmits FDA application for sotagliflozin for type 1 diabetes
- Lexicon Pharmaceuticals Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Lexicon Pharmaceuticals